NCT04334954View on ClinicalTrials.gov

SARS-COV2 Pandemic Serosurvey and Blood Sampling

CompletedOBSERVATIONAL
Enrollment

11,363

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

January 21, 2022

Conditions
SARS-COV2 Virus
Trial Locations (3)

15261

University of Pittsburgh, Pittsburgh

20892

National Institutes of Health Clinical Center, Bethesda

35233

University of Alabama, Birmingham

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT04334954 - SARS-COV2 Pandemic Serosurvey and Blood Sampling | Biotech Hunter | Biotech Hunter